TAT gene mutation analysis in three Palestinian kindreds with oculocutaneous tyrosinaemia type II; characterization of a silent exonic transversion that causes complete missplicing by exon 11 skipping
- PMID: 16917729
- DOI: 10.1007/s10545-006-0407-8
TAT gene mutation analysis in three Palestinian kindreds with oculocutaneous tyrosinaemia type II; characterization of a silent exonic transversion that causes complete missplicing by exon 11 skipping
Abstract
Deficiency of the hepatic cytosolic enzyme tyrosine aminotransferase (TAT) causes marked hypertyrosinaemia leading to painful palmoplantar hyperkeratoses, pseudodendritic keratitis and variable mental retardation (oculocutaneous tyrosinaemia type II or Richner-Hanhart syndrome). Parents may therefore seek prenatal diagnosis, but this is not possible by biochemical assays as tyrosine does not accumulate in amniotic fluid and TAT is not expressed in chorionic villi or amniocytes. Molecular analysis is therefore the only possible approach for prenatal diagnosis and carrier detection. To this end, we sought TAT gene mutations in 9 tyrosinaemia II patients from three consanguineous Palestinian kindreds. In two kindreds (7 patients), the only potential abnormality identified after sequencing all 12 exons and exon-intron boundaries was homozygosity for a silent, single-nucleotide transversion c.1224G > T (p.T408T) at the last base of exon 11. This was predicted to disrupt the 5' donor splice site of exon 11 and result in missplicing. However, as TAT is expressed exclusively in liver, patient mRNA could not be obtained for splicing analysis. A minigene approach was therefore used to assess the effect of c.1224G > T on exon 11 splicing. Transfection experiments with wild-type and c.1224G > T mutant minigene constructs demonstrated that c.1224G > T results in complete exon 11 skipping, illustrating the utility of this approach for confirming a putative splicing defect when cDNA is unavailable. Homozygosity for a c.1249C > T (R417X) exon 12 nonsense mutation (previously reported in a French patient) was identified in both patients from the third kindred, enabling successful prenatal diagnosis of an unaffected fetus using chorionic villous tissue.
Similar articles
-
The mutation spectrum and ethnic distribution of non-hepatorenal tyrosinemia (types II, III).Orphanet J Rare Dis. 2022 Dec 5;17(1):424. doi: 10.1186/s13023-022-02579-0. Orphanet J Rare Dis. 2022. PMID: 36471409 Free PMC article. Review.
-
Novel and recurrent mutations in the TAT gene in Tunisian families affected with Richner-Hanhart syndrome.Gene. 2013 Oct 15;529(1):45-9. doi: 10.1016/j.gene.2013.07.066. Epub 2013 Aug 13. Gene. 2013. PMID: 23954227
-
Clinical and mutational investigations of tyrosinemia type II in Northern Tunisia: identification and structural characterization of two novel TAT mutations.Mol Genet Metab. 2006 Jun;88(2):184-91. doi: 10.1016/j.ymgme.2006.02.006. Epub 2006 Mar 30. Mol Genet Metab. 2006. PMID: 16574453
-
Identification of two new mutations in the TAT gene in a Danish family with tyrosinaemia type II.Br J Dermatol. 2009 Mar;160(3):704-6. doi: 10.1111/j.1365-2133.2008.08888.x. Epub 2008 Oct 13. Br J Dermatol. 2009. PMID: 18945316 No abstract available.
-
Hereditary tyrosinaemia type I: from basics to progress in treatment.Ann Med. 2000 Nov;32(8):530-8. doi: 10.3109/07853890008998832. Ann Med. 2000. PMID: 11127930 Review.
Cited by
-
L-tyrosine induces DNA damage in brain and blood of rats.Neurochem Res. 2014 Jan;39(1):202-7. doi: 10.1007/s11064-013-1207-9. Epub 2013 Dec 3. Neurochem Res. 2014. PMID: 24297753
-
Relaxed evolution in the tyrosine aminotransferase gene tat in old world fruit bats (Chiroptera: Pteropodidae).PLoS One. 2014 May 13;9(5):e97483. doi: 10.1371/journal.pone.0097483. eCollection 2014. PLoS One. 2014. PMID: 24824435 Free PMC article.
-
Identification of a novel nonsynonymous mutation of EYA1 disrupting splice site in a Korean patient with BOR syndrome.Mol Biol Rep. 2014 Jul;41(7):4321-7. doi: 10.1007/s11033-014-3303-6. Epub 2014 Mar 4. Mol Biol Rep. 2014. PMID: 24590738
-
The mutation spectrum and ethnic distribution of non-hepatorenal tyrosinemia (types II, III).Orphanet J Rare Dis. 2022 Dec 5;17(1):424. doi: 10.1186/s13023-022-02579-0. Orphanet J Rare Dis. 2022. PMID: 36471409 Free PMC article. Review.
-
Tyrosine aminotransferase: biochemical and structural properties and molecular dynamics simulations.Protein Cell. 2010 Nov;1(11):1023-32. doi: 10.1007/s13238-010-0128-5. Epub 2010 Dec 10. Protein Cell. 2010. PMID: 21153519 Free PMC article.
References
Publication types
MeSH terms
Substances
Associated data
- Actions
- Actions
- Actions
LinkOut - more resources
Full Text Sources
Medical